查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924727

专利卵圆孔闭合装置市场按材料、手术、产品类型、最终用户和分销管道划分－全球预测（2026-2032 年）

Patent Foramen Ovale Occluder Market by Material Type, Procedure, Product Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，卵圆孔闭合装置的专利市值为 4.3892 亿美元，预计到 2026 年将成长至 4.9859 亿美元，预计到 2032 年将达到 11.4891 亿美元，复合年增长率为 14.73%。

主要市场统计数据
基准年 2025 4.3892亿美元
预计年份：2026年 4.9859亿美元
预测年份：2032年 1,148,910,000 美元
复合年增长率 (%) 14.73%

本文简要概述了影响卵圆孔未闭专利装置应用和策略重点的临床、监管和营运趋势。

卵圆孔封堵器材的临床和商业性格局融合了心臟病学、介入放射学和器材创新，为製造商、临床医生和医疗保健系统创造了一个充满活力的环境。过去十年，器械设计和材料日趋成熟，提高了手术安全性和解剖结构相容性。同时，临床医师也不断完善患者选择标准，以最大限度地提高治疗效果。这些进展使得讨论的重点从基本可行性转向了长期疗效、生活品质的改善以及影响医院采购和报销的卫生经济学。

材料创新、流程分散化、监管加强和数位商务如何从根本上改变卵圆孔未闭封堵器械的竞争格局和临床应用现状

多项变革正在重塑卵圆孔未闭（PFO）封堵器领域的竞争格局和临床动态，影响产品设计、市场推广策略以及相关人员的价值提案。首先，材料科学的进步促使人们重新重视镍钛合金基框架和聚酯等纺织介面，以优化封堵器的贴合性、渗透性和内皮化特性，从而推动设计人员开发更薄、更低轮廓的输送系统，以减少血管损伤并使其适用于不同的解剖结构。

评估2025年实施的关税如何重塑了PFO封盖供应链的采购、製造在地化、购买行为和分销策略。

2025年实施的关税的累积影响正波及植入式心血管器械（包括卵圆孔未闭封堵器）的供应链、采购流程和价格谈判动态。进口零件（例如精密镍钛合金、放射性标记和聚合物纤维）的关税带来的成本压力迫使製造商重新评估其筹资策略，一些公司将关键生产流程本地化，另一些公司则重新谈判供应商合约以缓解利润压力。这些调整并非孤立发生，而是与医院和诊所预算面临的现有压力相互作用，影响竞标结果和资金分配决策。

详细的細項分析揭示了终端用户环境、材料选择、流程方法、产品设计和分销管道如何驱动设备需求和商业化策略。

细分市场层面的趋势揭示了清晰的商业和临床需求，这些需求应指南卵圆孔未闭封堵器市场的产品开发和上市策略。从终端使用者角度检验，随着使用场所从门诊手术中心到心臟诊所再到医院，器械的需求也随之改变。门诊机构优先考虑简化的交付系统和快速的復健方案；心臟诊所需要经济高效的一次性产品和便利的预约安排；而医院则重视全面的临床支援、培训以及与机构采购流程相符的保固条款。

从区域战略观点来看，美洲、欧洲、中东和非洲以及亚太地区都需要量身定制的证据、定价和分销方法才能实现临床应用。

地理差异影响着临床实践模式、监管预期和采购框架，这些因素共同塑造了卵圆孔未闭封堵器製造商和供应商的区域战略重点。在美洲，公立和私立医疗机构的采购行为往往侧重于可证实的临床疗效和医疗总成本，这要求製造商将循证医学证据的产生与定价策略相结合，以支持药物上市和心臟病治疗项目的实施。此外，当高品质的註册资料支援特定器材的特性时，北美临床网路也会推动实践变革的快速普及。

竞争格局和合作伙伴关係分析揭示了现有设备製造商、专业创新者和通路策略将如何决定市场份额和长期市场定位。

PFO封堵器领域的竞争格局呈现出多元化的态势，既有成熟的医疗技术公司，也有专注于器材创新的厂商，还有灵活敏捷的区域供应商，它们各自追求差异化的价值提案。主要参与企业致力于整合策略，将产品改进与可靠的临床证据和可扩展的生产能力相结合，以满足医院系统和大量采购的需求。中型和新兴企业通常透过设计创新来脱颖而出，例如缩短植入路径、采用新型组织介面和简化植入机制，以及建立重点临床伙伴关係关係，以期获得早期真实世界的研究结果，从而加速临床医生对产品的接受度。

为加强韧性、产生证据和改善管道合作，以促进卵圆孔未闭封堵器持续推广应用，製造商和医疗系统合作伙伴可提出的实用建议

产业领导者应采取一系列切实可行的措施，以维持卵圆孔未闭封堵器领域的成长并降低新兴风险。优先考虑材料和供应链多元化，以降低关税衝击风险，并确保镍钛合金和植入物织物等关键材料的稳定供应。这包括评估双重采购安排、精密製造的近岸外包方案以及在经济可行的情况下进行垂直整合。同时，应加快对真实世界数据 (RWE) 和纵向註册研究的投资，以证明产品在不同患者亚群中的耐久性和安全性，因为支付方和采购委员会越来越需要可靠的临床结果来支持器械的选择。

采用稳健的混合方法研究途径，整合临床医师访谈、负责人访谈、监管技术分析和交叉检验综合分析，以支援策略洞察。

这些研究成果采用了混合方法，结合了定性访谈、有针对性的二手研究以及器械层面的技术评估，以确保对卵圆孔未闭（PFO）封堵器械市场格局的全面了解。主要研究包括对门诊手术中心、心臟诊所和医院的临床医生、负责直接竞标谈判的采购主管以及透过製造商网站、第三方电商平台和零售管道（例如医疗设备批发商和药局）开展业务的分销合作伙伴进行半结构式访谈。这些访谈深入分析了器械发展趋势、手术流程考量以及管道绩效。

对推动卵圆孔未闭封堵器领域应用和持续创新必须整合的关键临床、商业和营运问题进行全面分析

总而言之，卵圆孔封堵器市场正处于一个转折点，其驱动因素包括材料创新、手术流程分散化、监管机构对真实世界数据的重视以及不断演变的分销模式。那些优先考虑稳健供应链、有针对性地收集临床数据以及为门诊心臟诊所和医院提供差异化产品组合的製造商，将更有利于满足临床医生多样化的需求和采购部门的期望。关注镍钛合金和聚酯等材料及其与器械结构、输送系统直径和组织整合的相互作用，仍然是临床接受度和长期疗效的关键所在。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依材料类型分類的专利卵圆孔闭合装置市场

  • 镍钛诺
  • 聚酯纤维

9. 依手术方式分類的卵圆孔闭合专利器械市场

  • 血管内手术
  • 经皮手术

第十章 依产品类型分類的专利卵圆孔闭合装置市场

  • 窗户类型
  • 非开窗型

第十一章 依最终用户分類的专利卵圆孔闭合装置市场

  • 门诊手术中心
  • 心臟诊所
  • 医院

第十二章 专利卵圆孔闭合装置市场（依分销管道划分）

  • 在线的
  • 离线

第十三章 专利卵圆孔闭合装置市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依组别分類的专利卵圆孔闭合装置市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国专利卵圆孔闭合装置市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国专利卵圆孔闭合装置市场

第十七章 中国专利卵圆孔闭合装置市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SAS
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Elixir Medical Corporation
  • Gunze Limited
  • Kyoto Medical Planning Co., Ltd.
  • Lincotek Medical SpA
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Limited
  • QualiMed Innovative Medizinprodukte GmbH
  • REVA Medical, Inc.
  • Sahajanand Medical Technologies Private Limited
  • Shanghai Bio-heart Biological Technology Co., Ltd.
  • Xenogenics Corporation
Product Code: MRR-7A380DA7C459

The Patent Foramen Ovale Occluder Market was valued at USD 438.92 million in 2025 and is projected to grow to USD 498.59 million in 2026, with a CAGR of 14.73%, reaching USD 1,148.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 438.92 million
Estimated Year [2026] USD 498.59 million
Forecast Year [2032] USD 1,148.91 million
CAGR (%) 14.73%

A concise orientation to the clinical, regulatory, and operational dynamics shaping patent foramen ovale occluder adoption and strategic priorities

The clinical and commercial landscape for patent foramen ovale occluders intersects cardiology, interventional radiology, and device innovation, creating a dynamic environment for manufacturers, clinicians, and health systems. Over the past decade, device designs and materials have matured to improve procedural safety and anatomical compatibility, while clinicians have refined patient selection criteria to maximize therapeutic benefit. These developments have shifted the conversation from basic feasibility toward long-term outcomes, quality of life improvements, and health economic considerations that influence hospital procurement and reimbursement discussions.

As adoption spreads beyond tertiary centers into more distributed care settings, stakeholders must balance clinical evidence with operational realities, such as procedure throughput, inventory management, and the need for training and proctoring. Simultaneously, regulatory scrutiny and post-market surveillance are demanding more granular clinical data and device traceability, which in turn affects commercialization timelines and manufacturer responsibilities. The interplay between technology evolution, clinical practice patterns, and health system procurement creates both opportunities and constraints, and it necessitates focused strategic planning by device developers and service providers to align investments with emergent clinical pathways and purchaser expectations.

How material innovation, procedural decentralization, regulatory rigor, and digital commerce are fundamentally reshaping the PFO occluder competitive and clinical landscape

Several transformative shifts are recalibrating the competitive and clinical dynamics of the PFO occluder field, with implications for product design, go-to-market approaches, and stakeholder value propositions. First, materials science advances have driven a renewed emphasis on nitinol-based frameworks and textile interfaces such as polyester to optimize conformability, radiopacity, and endothelialization profiles, encouraging designers to pursue thinner profiles and lower-profile delivery systems that reduce vascular trauma and enable use in diverse anatomies.

Second, procedural innovation has expanded the settings in which these devices are deployed, enabling a transition from solely hospital-based interventions to higher-throughput ambulatory surgical centers and specialized cardiac clinics where procedural efficiency and fast recovery are paramount. Third, regulatory expectations and payer scrutiny have elevated the importance of real-world evidence and long-term follow-up, prompting manufacturers to invest in registries and post-market studies that validate durability and safety. Fourth, digital integration-ranging from improved imaging guidance to e-commerce and digital tender platforms-has modified how clinicians discover, procure, and train on devices, thereby compressing sales cycles and altering distributor value propositions. Together, these shifts are encouraging manufacturers to prioritize modularity, data generation, and multi-channel commercialization strategies to capture market relevance in an increasingly evidence-driven environment.

Assessing how 2025 tariff measures have reshaped sourcing, manufacturing localization, procurement behavior, and distribution strategies across PFO occluder supply chains

The cumulative impact of tariffs introduced in 2025 has rippled through supply chains, procurement practices, and price negotiation dynamics for implantable cardiovascular devices, including PFO occluders. Tariff-driven cost pressure on imported components such as precision nitinol alloys, radiopaque markers, and polymer textiles has forced manufacturers to reassess sourcing strategies, pushing some to localize key manufacturing steps and others to renegotiate supplier contracts to mitigate margin erosion. These adjustments have not occurred in isolation; they interact with existing pressures on hospital and clinic budgets, influencing tender outcomes and capital allocation decisions.

Procurement teams have responded by intensifying value analysis activities and expanding clinical-economics assessments to justify device selection in the face of higher landed costs. Distribution networks have been re-evaluated as well: direct tender processes have gained prominence where scale economies can offset tariff impacts, while e-commerce channels and third-party platforms have been leveraged to streamline smaller purchases and maintain continuity for outpatient centers. For manufacturers without scale or localized production, tariff-driven cost increases have heightened consolidation risk as smaller players face a more challenging commercial environment. In parallel, clinicians and health systems are exploring alternative device designs and procedural pathways that limit dependency on high-cost imported subcomponents, accelerating demand for suppliers who can demonstrate resilient sourcing and transparent cost structures.

In-depth segmentation insights revealing how end-user settings, material choices, procedural approaches, product design, and distribution channels dictate device requirements and commercialization tactics

Segment-level dynamics reveal distinct commercial and clinical imperatives that should inform product development and go-to-market strategies across the PFO occluder landscape. When examining the end user dimension, the device narrative changes as the setting shifts from ambulatory surgical centers to cardiac clinics and hospitals: ambulatory settings prioritize streamlined delivery systems and rapid recovery profiles, cardiac clinics demand cost-effective disposables and ease of scheduling, and hospitals emphasize comprehensive clinical support, training, and warranty terms that align with institutional procurement processes.

Material type creates another axis of differentiation where nitinol frameworks offer superelasticity and fatigue resistance attractive for conformable closure devices, while polyester components play a complementary role in promoting tissue ingrowth and sealing; design trade-offs between these materials influence delivery system diameter, visibility under imaging, and endothelialization timelines. Procedural segmentation between endovascular surgery and percutaneous surgery affects clinician preferences and device specifications, with endovascular techniques often prioritizing compatibility with complex vascular access paths and percutaneous approaches emphasizing device delivery simplicity and reduced patient recovery time. Product-type distinctions between fenestrated and non-fenestrated designs introduce clinical selection criteria based on defect anatomy and anticipated hemodynamic outcomes, shaping both labeling strategies and clinician education efforts. Distribution channel behavior further modifies commercial execution: direct tender activity favors price transparency and contract compliance, e-commerce-whether via manufacturer websites or third-party platforms-supports just-in-time procurement for lower-volume sites, and retail pathways through medical device distributors and pharmacies enhance reach into decentralized care environments but require robust logistics and clinical support models.

Regional strategic perspectives showing how the Americas, Europe Middle East & Africa, and Asia-Pacific each require tailored evidence, pricing, and distribution approaches to gain clinical traction

Geographic variation influences clinical practice patterns, regulatory expectations, and procurement frameworks that collectively shape regional strategic priorities for PFO occluder manufacturers and suppliers. In the Americas, institutional purchasing behavior in both public and private health systems often places a premium on demonstrable clinical outcomes and total cost of care, and manufacturers must align evidence generation and pricing strategies to support formulary inclusion and cardiac program adoption. North American clinical networks also drive rapid dissemination of practice changes once high-quality registry data supports a given device profile.

In Europe, the Middle East & Africa, heterogeneous regulatory pathways and reimbursement models require adaptable market entry strategies and local evidence packages. CE-mark equivalence and divergent national HTA processes necessitate targeted clinical and economic dossiers, while distribution partnerships often play a critical role in navigating fragmented procurements across regions. The Asia-Pacific landscape combines large, high-volume public tenders with emerging private markets; supplier success here depends on scalable manufacturing, flexible pricing models, and culturally informed clinician engagement that addresses differences in procedural preference and hospital infrastructure. Across all regions, logistical considerations-including tariff exposure, component sourcing, and distribution network resiliency-remain central to commercial planning and influence the relative attractiveness of direct tender negotiations, digital sales channels, and distributor-led retail pathways.

Competitive and collaborator landscape analysis highlighting how device incumbents, focused innovators, and channel strategies determine traction and long-term positioning

Competitive dynamics in the PFO occluder sector reflect a mix of established medical technology firms, specialized device innovators, and nimble regional suppliers, each pursuing differentiated value propositions. Leading players focus on integrated strategies that combine product refinement with robust clinical evidence and scalable manufacturing capabilities to meet the demands of hospital systems and high-volume tenders. Mid-sized and emerging companies often differentiate through design innovation-such as reduced delivery profiles, novel tissue-contact surfaces, or simplified deployment mechanisms-and by cultivating focused clinical partnerships to generate early real-world outcomes that can accelerate clinician adoption.

Smaller vendors and contract manufacturers may leverage agility to serve niche anatomic or procedural needs, but they face challenges related to supply chain resilience and access to broad distribution networks. Across the competitive set, collaborations between manufacturers, imaging technology providers, and academic centers are increasingly common, enabling co-development of procedure-specific guidance and training programs that de-risk adoption for clinicians. Additionally, distribution strategies vary widely: some firms prioritize direct tender and hospital contracting to capture institutional volume, while others pursue omnichannel approaches that balance manufacturer websites, third-party e-commerce platforms, and distributor or pharmacy retail relationships to maximize reach in outpatient and community care settings.

Actionable recommendations for manufacturers and health system partners to improve resilience, evidence generation, and channel alignment for sustained PFO occluder adoption

Industry leaders should adopt a set of pragmatic, actionable measures to sustain growth and mitigate emerging risks in the PFO occluder space. Prioritize material and supply-chain diversification to reduce exposure to tariff shocks and to secure access to critical inputs such as nitinol and implantable-grade textiles; this includes evaluating dual-sourcing arrangements, nearshoring options for precision manufacturing, and vertical integration where economically viable. Concurrently, invest in real-world evidence generation and longitudinal registries that demonstrate durability and safety across diverse patient subgroups, since payers and procurement committees increasingly require robust clinical outcomes to justify device selection.

Optimize commercialization by aligning product variants to end-user needs: tailor lower-profile, cost-efficient configurations for ambulatory surgical centers and cardiac clinics while offering bundled service and training packages for hospitals that require deeper clinical support. Embrace omnichannel distribution strategies that incorporate direct tender capabilities for institutional buyers, e-commerce platforms for decentralized purchasing, and distributor partnerships to penetrate retail and pharmacy channels effectively. Finally, strengthen stakeholder engagement through clinician training programs, proctorship, and transparent value communication that ties device attributes to procedural efficiency, patient recovery, and downstream resource utilization, thereby accelerating adoption in both centralized and distributed care environments.

A robust mixed-methods research approach integrating clinician interviews, procurement interviews, regulatory and technical analysis, and cross-validated synthesis to underpin strategic insights

The research underpinning these insights used a mixed-methods approach that combines primary qualitative interviews, targeted secondary analysis, and device-level technical assessments to ensure a multi-faceted understanding of the PFO occluder landscape. Primary research included semi-structured interviews with clinicians across ambulatory surgical centers, cardiac clinics, and hospitals, procurement leaders responsible for direct tender negotiations, and distribution partners operating through manufacturer websites, third-party e-commerce platforms, and retail channels such as medical device distributors and pharmacies. These conversations informed device preference trends, procedural workflow considerations, and channel performance observations.

Secondary sources encompassed regulatory approvals, device labeling, clinical registry summaries, peer-reviewed literature, and public tender documentation to validate clinical claims and procurement dynamics. Technical assessments compared material properties of nitinol and polyester components, delivery system profiles, and variant design implications for fenestrated versus non-fenestrated configurations. Data synthesis employed triangulation across sources to reconcile differing stakeholder perspectives and to surface robust, actionable conclusions, while quality checks and cross-validation steps ensured consistency and plausibility of reported trends and strategic implications.

Concluding synthesis of clinical, commercial, and operational imperatives that must be integrated to accelerate adoption and sustain innovation in the PFO occluder sector

In summary, the patent foramen ovale occluder market is at an inflection point driven by material innovation, procedural decentralization, regulatory emphasis on real-world evidence, and evolving distribution models. Manufacturers that prioritize resilient supply chains, targeted clinical data generation, and differentiated product configurations tailored to ambulatory centers, cardiac clinics, and hospitals will be best positioned to meet diverse clinician needs and procurement expectations. Attention to materials such as nitinol and polyester-and the way these interact with device profile, delivery system diameter, and tissue integration-remains central to clinical acceptance and long-term performance.

Tariff-related pressures introduced in 2025 have amplified the importance of sourcing flexibility and cost transparency, prompting a recalibration of commercial strategies that favor direct tender capability and flexible e-commerce or distributor-based retail execution for decentralized care. Regional nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific require tailored evidence generation and pricing approaches to align with local regulatory and reimbursement realities. Ultimately, success will depend on the ability of organizations to integrate clinical, operational, and commercial insights into cohesive strategies that reduce adoption friction, demonstrate value to payers and providers, and sustain product innovation over the long term.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patent Foramen Ovale Occluder Market, by Material Type

  • 8.1. Nitinol
  • 8.2. Polyester

9. Patent Foramen Ovale Occluder Market, by Procedure

  • 9.1. Endovascular Surgery
  • 9.2. Percutaneous Surgery

10. Patent Foramen Ovale Occluder Market, by Product Type

  • 10.1. Fenestrated
  • 10.2. Non Fenestrated

11. Patent Foramen Ovale Occluder Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Clinics
  • 11.3. Hospitals

12. Patent Foramen Ovale Occluder Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Patent Foramen Ovale Occluder Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Patent Foramen Ovale Occluder Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Patent Foramen Ovale Occluder Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Patent Foramen Ovale Occluder Market

17. China Patent Foramen Ovale Occluder Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Amaranth Medical, Inc.
  • 18.7. Arterial Remodeling Technologies SAS
  • 18.8. B. Braun Melsungen AG
  • 18.9. Biosensors International Group, Ltd.
  • 18.10. BIOTRONIK SE & Co. KG
  • 18.11. Boston Scientific Corporation
  • 18.12. C. R. Bard, Inc.
  • 18.13. Elixir Medical Corporation
  • 18.14. Gunze Limited
  • 18.15. Kyoto Medical Planning Co., Ltd.
  • 18.16. Lincotek Medical S.p.A.
  • 18.17. Meril Life Sciences Pvt. Ltd.
  • 18.18. MicroPort Scientific Corporation
  • 18.19. OrbusNeich Medical Company Limited
  • 18.20. QualiMed Innovative Medizinprodukte GmbH
  • 18.21. REVA Medical, Inc.
  • 18.22. Sahajanand Medical Technologies Private Limited
  • 18.23. Shanghai Bio-heart Biological Technology Co., Ltd.
  • 18.24. Xenogenics Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY ENDOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY ENDOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY ENDOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PERCUTANEOUS SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PERCUTANEOUS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PERCUTANEOUS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY FENESTRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY FENESTRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY FENESTRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY NON FENESTRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY NON FENESTRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY NON FENESTRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 99. GCC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. GCC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GCC PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 117. G7 PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. G7 PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. G7 PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NATO PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 123. NATO PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NATO PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NATO PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)